Mora Vidal, Regina <br/><br/>
Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer.  [electronic resource] 

 -  Urology  Feb 2018 
 - 225.e1-225.e7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2017.10.041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Cell Line, Tumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride--therapeutic use<br/>Humans<br/>Lapatinib--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Signal Transduction<br/>Urinary Bladder Neoplasms--drug therapy<br/>p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors